Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, I: analysis of cases

BACKGROUND: An advance in the treatment of schizophrenia is the development of long-acting intramuscular formulations of antipsychotics, such as olanzapine long-acting injection (LAI). During clinical trials, a post-injection syndrome characterized by signs of delirium and/or excessive sedation was...

Descripción completa

Detalles Bibliográficos
Autores principales: Detke, Holland C, McDonnell, David P, Brunner, Elizabeth, Zhao, Fangyi, Sorsaburu, Sebastian, Stefaniak, Victoria J, Corya, Sara A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895589/
https://www.ncbi.nlm.nih.gov/pubmed/20537128
http://dx.doi.org/10.1186/1471-244X-10-43

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895589/
https://www.ncbi.nlm.nih.gov/pubmed/20537128
http://dx.doi.org/10.1186/1471-244X-10-43

Ejemplares similares